Terms: = Lung cancer AND SMARCE1, ENSG00000073584, 6605, BAF57, Q969G3 AND Treatment
2 results:
1. Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation.
Petanidis S; Domvri K; Porpodis K; Anestakis D; Freitag L; Hohenforst-Schmidt W; Tsavlis D; Zarogoulidis K
Biomed Pharmacother; 2020 Feb; 122():109461. PubMed ID: 31918262
[TBL] [Abstract] [Full Text] [Related]
2. smarce1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer.
Papadakis AI; Sun C; Knijnenburg TA; Xue Y; Grernrum W; Hölzel M; Nijkamp W; Wessels LF; Beijersbergen RL; Bernards R; Huang S
Cell Res; 2015 Apr; 25(4):445-58. PubMed ID: 25656847
[TBL] [Abstract] [Full Text] [Related]
